Seer (NASDAQ:SEER) Shares Down 0.5% - Time to Sell?

Key Points

• Seer shares slipped 0.5% to $1.94 in midday trading, with volume 25% below the average session level. The company has a market capitalization of approximately $107.4 million.
• Analyst sentiment remains mixed: Weiss Ratings reiterated a “sell (D-)” rating, while the broader analyst consensus is “Buy,” based on two Strong Buy ratings and one Sell rating. The average price target is $4.00.
• Seer’s latest quarterly results fell short of expectations, reporting an EPS loss of $0.31 versus the estimated $0.27 loss and revenue of $3.10 million versus the $3.55 million consensus. The company also posted a negative net margin of 478.05%.

Seer, Inc. (NASDAQ:SEER - Get Free Report) was down 0.5% during mid-day trading on Wednesday . The stock traded as low as $1.93 and last traded at $1.94. 147,503 shares changed hands during mid-day trading, a decline of 25% from the average session volume of 195,644 shares. The stock had previously closed at $1.95.

Analyst Ratings Changes

Separately, Weiss Ratings restated a "sell (d-)" rating on shares of Seer in a research report on Friday, July 17th. Two analysts have rated the stock with a Strong Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Seer presently has a consensus rating of "Buy" and an average price target of $4.00.

Seer Stock Performance

The business has a 50 day simple moving average of $2.06 and a two-hundred day simple moving average of $1.90. The firm has a market capitalization of $107.42 million, a P/E ratio of -1.59 and a beta of 1.50.

Seer (NASDAQ:SEER - Get Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported ($0.31) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.27) by ($0.04). Seer had a negative net margin of 478.05% and a negative return on equity of 27.23%. The business had revenue of $3.10 million for the quarter, compared to the consensus estimate of $3.55 million.

Institutional Investors Weigh In On Seer

Hedge funds have recently bought and sold shares of the stock. Occudo Quantitative Strategies LP bought a new position in shares of Seer in the 2nd quarter worth $25,000. Marshall Wace LLP bought a new stake in shares of Seer during the 4th quarter worth $85,000. Quadrature Capital Ltd bought a new stake in shares of Seer during the 4th quarter worth $101,000. Barclays PLC grew its position in Seer by 685.0% in the fourth quarter. Barclays PLC now owns 60,717 shares of the company's stock worth $111,000 after acquiring an additional 52,982 shares in the last quarter. Finally, Marquette Asset Management LLC purchased a new position in Seer in the second quarter worth $103,000. 75.20% of the stock is currently owned by institutional investors.

Seer Company Profile

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer's platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company's flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.